Average Co-Inventor Count = 3.01
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sunovion Pharmaceuticals Inc. (20 from 130 patents)
2. Epizyme, Inc. (18 from 158 patents)
3. Pgi Drug Discovery LLC (6 from 16 patents)
4. Blueprint Medicines Corporation (2 from 60 patents)
5. Psychogenics Inc. (1 from 7 patents)
6. Campbell, John Emmerson (0 patent)
7. Shao, Liming (0 patent)
8. Campbell, Una (0 patent)
9. Hanania, Taleen G. (0 patent)
10. John Emmerson Campbell (0 patent)
11. Una Campbell (0 patent)
12. Liming Shao (0 patent)
13. Taleen G. Hanania (0 patent)
40 patents:
1. 12172983 - EGFR inhibitors
2. 12116358 - Substituted indoles and methods of use thereof
3. 11718602 - EGFR inhibitors
4. 11685732 - MYST family histone acetyltransferase inhibitors
5. 11672800 - Combination therapies with EHMT2 inhibitors
6. 11642348 - Substituted benzene compounds
7. 11332462 - Heteroaryl compounds and methods of use thereof
8. 10894033 - Multicyclic compounds and methods of use thereof
9. 10604536 - Substituted cyclopropanes as PDE-10 inhibitors
10. 10570156 - Substituted imidazo[1,2-a]pyridines as PDE-10 inhibitors
11. 10562916 - Substituted quinoxalines as PDE-10 inhibitors
12. 10556890 - Heteroaryl compounds and methods of use thereof
13. 10189825 - Heteroaryl compounds and methods of use thereof
14. 10174019 - Substituted 6,5-fused bicyclic heteroaryl compounds
15. 10150759 - 1,4-pyridone bicycic heteroaryl compounds